Related Experiment Video
Updated: Jul 5, 2025

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
Published on: April 4, 2019
Respiratory syncytial virus: A new era
J Ruiz-Galiana, R Cantón, P De Lucas Ramos
1Servicio de Microbiología Clínica y Enfermedades Infecciosas del Hospital General Universitario Gregorio Marañón, Universidad Complutense. CIBERES. Ciber de Enfermedades Respiratorias. Madrid, Spain. emilio.bouza@gmail.com.
Respiratory syncytial virus (RSV) is now easier to diagnose and affects all ages, not just children. Advances in treatments and vaccines offer new hope for managing this significant public health concern.
Area of Science:
- Virology
- Epidemiology
- Public Health
Background:
- Respiratory syncytial virus (RSV) is a significant public health issue with evolving epidemiology.
- Historically considered a pediatric illness, RSV now impacts all age groups, especially the elderly and immunocompromised.
Purpose of the Study:
- To review current knowledge and resources for managing RSV infection in light of recent advancements.
- To address key questions regarding RSV, particularly its impact and management in Spain.
Main Methods:
- Review of recent scientific literature and clinical guidelines.
- Formulation of key questions by the COVID and Emerging Pathogens Committee of ICOMEM.
Main Results:
- Improved diagnostic capabilities provide more reliable and rapid RSV confirmation.
- New therapeutic and prophylactic options, including monoclonal antibodies and vaccines, are now available.
- Understanding of RSV epidemiology has expanded, recognizing its broader impact across age demographics.
Conclusions:
- RSV is a widespread infection affecting all ages, necessitating updated management strategies.
- Recent advancements in diagnostics, therapeutics, and vaccines offer improved control and prevention of RSV.
- This review provides valuable insights for healthcare professionals and the public regarding RSV in Spain.
More Related Videos
09:08Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus
Published on: July 27, 2021
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Related Concept Videos
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-III
The Respiratory System